--- a
+++ b/clusters/9knumclustersv2/clust_1500.txt
@@ -0,0 +1,27 @@
+For patients with solid tumors without known bone marrow involvement:
+For patients with solid tumors without known bone marrow involvement:
+For patients with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
+Peripheral absolute neutrophil count (ANC) >= /uL for patients with solid tumors without bone marrow involvement
+Peripheral absolute neutrophil count (ANC) >= /uL for patients with solid tumors and known bone marrow metastatic disease
+Platelet count >= ,/uL for patients with solid tumors and known bone marrow metastatic disease
+Within  days of treatment initiation: Absolute neutrophil count (ANC) >=  cells/mm^ (or >=  in subjects with bone marrow involvement)
+Absolute neutrophil count (ANC) >= /uL for subjects without bone marrow involvement
+For patients with solid tumors without known bone marrow involvement:
+Absolute neutrophil count (ANC) ? /uL\r\n* The above criteria do not have to be met if the patient has bone marrow involvement of tumor
+Subjects must have adequate Bone Marrow function defined as: For patients without bone marrow involvement:  Peripheral absolute neutrophil count (ANC) >/uL
+Absolute neutrophil count >= /mm^ in the absence of bone marrow involvement; patients with bone marrow involvement are not required to have a minimum absolute neutrophil count
+For subjects with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
+Absolute neutrophil count (ANC) >= . x ^/L or < . x ^/L but >= . due to > % marrow involvement\r\n* Patients who entered the trial prior to June ,  were restricted to > % marrow involvement
+Bone marrow function: absolute neutrophil count ?,/L, and platelets ? ,/ L;
+For subjects with solid tumors without known bone marrow involvement: \r\n*Peripheral absolute neutrophil count (ANC) ? /mm^
+Absolute neutrophil count (ANC) >= , /mcL if no bone marrow involvement, ANC >=  /mcL if documented bone marrow involvement
+For patients with solid tumors without bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /uL
+For patients with solid tumors and known bone marrow metastatic disease: peripheral absolute neutrophil count (ANC) >= /uL
+For patients with solid tumors without bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
+For patients with solid tumors without known bone marrow involvement: peripheral absolute neutrophil count (ANC) >= /mm^
+Absolute neutrophil count (ANC) >= ,/uL unless due to bone marrow involvement
+Part : absolute neutrophil count (ANC) >= . x ^/L; Part : ANC >= . x ^/L if there is bone marrow involvement, >= . x ^/L if there is no bone marrow involvement
+PART B: FOR PATIENTS WITHOUT KNOWN BONE MARROW INVOLVEMENT
+absolute neutrophil count >,/?L in absence of bone marrow involvement
+Absolute neutrophil count (ANC) >= ,; patients with bone marrow involvement are allowed at the investigators discretion regardless of cytopenias
+Absolute Neutrophil Count (ANC) ? . x /L or ? . x /L (with bone marrow involvement with DLBCL)